Recruiting
Phase 1

Ruxolitinib & T-Regs

Sponsor:

Cellenkos, Inc.

Code:

NCT05423691

Conditions

Myelofibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CK0804

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information